PAVmed Inc. Research and Development in Process
PAVmed Inc. (PAVM) reported Research and Development in Process of $133.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2023-03-14
- PAVmed Inc. research and development in process for the quarter ending 2021-12-31 was $0.00.
- PAVmed Inc. research and development in process for the quarter ending 2021-09-30 was $0.00.
- PAVmed Inc. research and development in process for fiscal 2021 was $133.00K.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $0.00 derived: sum of 2 quarters · filed 2023-03-14 | $133.00K 10-K · filed 2023-03-14 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $133.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $133.00K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InspireMD, Inc. (NSPR) | $0.033B | ||
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |